Evidence map›Paper›PMID 39113144›Full record

ArticleJournal of translational medicine2024

Multi-omics analysis reveals a feedback loop amplifying immune responses in acute graft-versus-host disease due to imbalanced gut microbiota and bile acid metabolism.

Lijie Han, Xianlei Sun, Jingjing Kong, Jin Li, Kai Feng, Yanliang Bai, Xianjing Wang, Zhenhua Zhu, Fengyuan Yang, Qingzhou Chen and 15 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Gut microbiota and acute graft-versus-host disease.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Lijie Han *Translational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xianlei Sun *Basic Medical Research Center, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Jingjing Kong *Translational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jin LiTranslational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Kai FengDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yanliang BaiDepartment of Hematology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
Xianjing WangDepartment of Hematology, The Third People's Hospital of Zhengzhou, Zhengzhou, 450000, Henan, China.
Zhenhua ZhuDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Fengyuan YangBasic Medical Research Center, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Qingzhou ChenDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Mengmeng ZhangTranslational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Baohong YueDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiaoqian WangDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Liyan FuDepartment of Laboratory Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Yaoyao ChenDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Qiankun YangDepartment of Blood Transfusion, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Shuya WangDepartment of Blood Transfusion, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Qingxuan XinDepartment of Laboratory Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Nannan SunTranslational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Danfeng ZhangTranslational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yiwei ZhouTranslational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yanxia GaoDepartment of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Junwei ZhaoDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. junweizhao@alumni.sjtu.edu.cn.
Yong JiangHenan Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine and Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. jiang48231@163.com.
Rongqun GuoTranslational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. guorq2007@163.com.ORCID 0000-0002-1238-4772

Funding

National Natural Science Foundation of China 82100240
6 · The paper itself

Abstract

Acute graft-versus-host disease (aGVHD) is primarily driven by allogeneic donor T cells associated with an altered composition of the host gut microbiome and its metabolites. The severity of aGVHD after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is not solely determined by the host and donor characteristics; however, the underlying mechanisms remain unclear. Using single-cell RNA sequencing, we decoded the immune cell atlas of 12 patients who underwent allo-HSCT: six with aGVHD and six with non-aGVHD. We performed a fecal microbiota (16SrRNA sequencing) analysis to investigate the fecal bacterial composition of 82 patients: 30 with aGVHD and 52 with non-aGVHD. Fecal samples from these patients were analyzed for bile acid metabolism. Through multi-omic analysis, we identified a feedback loop involving "immune cell-gut microbes-bile acid metabolites" contributing to heightened immune responses in patients with aGVHD. The dysbiosis of the gut microbiota and disruption of bile acid metabolism contributed to an exaggerated interleukin-1 mediated immune response. Our findings suggest that resistin and defensins are crucial in mitigating against aGVHD. Therefore, a comprehensive multi-omic atlas incorporating immune cells, gut microbes, and bile acid metabolites was developed in this study and used to propose novel, non-immunosuppressive approaches to prevent aGVHD.

Indexed as

Bile Acids and SaltsFecesGastrointestinal MicrobiomeGraft vs Host DiseaseAcute DiseaseAdultFeedback, PhysiologicalFemaleHematopoietic Stem Cell TransplantationHumansImmunityMaleMetabolomicsMiddle AgedMultiomicsBile Acids and Salts

Identifiers

PMID39113144
PMCPMC11308528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.